|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 199.15 USD | +0.12% |
|
-7.85% | +13.16% |
| 07-08 | Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says | MT |
| 07-08 | BofA Securities Adjusts Biogen Price Target to $217 From $203 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BIOGEN INC. | Biopharmaceuticals | +0.12% | -7.85% | +13.16% | +48.39% | -44.40% | 29.4B |  |  | |
- Stock Market
- Stocks
- BIIB Stock
- Charts Biogen Inc.
- Comparison Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
